Fintel reports that on April 28, 2023, Mizuho maintained coverage of Idex (NYSE:IEX) with a Neutral recommendation.
Analyst Price Forecast Suggests 20.45% Upside
As of April 24, 2023, the average one-year price target for Idex is 250.34. The forecasts range from a low of 227.25 to a high of $294.00. The average price target represents an increase of 20.45% from its latest reported closing price of 207.83.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Idex is 3,311MM, an increase of 1.06%. The projected annual non-GAAP EPS is 8.60.
What is the Fund Sentiment?
There are 1354 funds or institutions reporting positions in Idex. This is an increase of 74 owner(s) or 5.78% in the last quarter. Average portfolio weight of all funds dedicated to IEX is 0.34%, an increase of 11.33%. Total shares owned by institutions increased in the last three months by 1.22% to 89,784K shares. 
The put/call ratio of IEX is 5.36, indicating a bearish outlook.
What are Other Shareholders Doing?
Price T Rowe Associates holds 3,270K shares representing 4.33% ownership of the company. In it's prior filing, the firm reported owning 2,964K shares, representing an increase of 9.36%. The firm increased its portfolio allocation in IEX by 23.77% over the last quarter.
Wellington Management Group Llp holds 2,810K shares representing 3.72% ownership of the company. In it's prior filing, the firm reported owning 2,914K shares, representing a decrease of 3.70%. The firm increased its portfolio allocation in IEX by 3.72% over the last quarter.
Alliancebernstein holds 2,737K shares representing 3.62% ownership of the company. In it's prior filing, the firm reported owning 2,688K shares, representing an increase of 1.78%. The firm increased its portfolio allocation in IEX by 8.13% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,293K shares representing 3.03% ownership of the company. In it's prior filing, the firm reported owning 2,251K shares, representing an increase of 1.83%. The firm increased its portfolio allocation in IEX by 7.48% over the last quarter.
PRNHX - T. Rowe Price New Horizons Fund holds 2,049K shares representing 2.71% ownership of the company. In it's prior filing, the firm reported owning 1,733K shares, representing an increase of 15.41%. The firm increased its portfolio allocation in IEX by 38.35% over the last quarter.
Idex Background Information
(This description is provided by the company.)
IDEX is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you're driving has a BAND-IT® clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life® rescue tool may have saved your life. If you or a family member is battling cancer, your doctor may have tested your DNA in a quest to find the best targeted medicine for you. It's likely your DNA test was run on equipment that contains components made by our growing IDEX Health & Science team. Founded in 1988 with three small, entrepreneurial manufacturing companies, IDEX is proud to say that IDEX now call 40 diverse businesses around the world part of the IDEX family. With 7,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global $2+ billion company committed to making trusted solutions that improve lives.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
